XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.9873
+0.0162 (1.67%)
At close: Jan 16, 2026, 4:00 PM EST
0.9271
-0.0602 (-6.10%)
After-hours: Jan 16, 2026, 7:26 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $9.03 million as of January 16, 2026. Its market cap has decreased by -57.93% in one year.
Market Cap
9.03M
Enterprise Value
8.84M
1-Year Change
-57.93%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $9.03M, a decrease of -94.99%. That is a compound annual growth rate of -13.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 9.03M | 26.71% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |